Frank Stokes - 17 Jun 2021 Form 4 Insider Report for EXAGEN INC. (XGN)

Role
Director
Signature
/s/ Kamal Adawi, as attorney-in-fact
Issuer symbol
XGN
Transactions as of
17 Jun 2021
Transactions value $
$0
Form type
4
Filing time
21 Jun 2021, 08:39:19 UTC
Previous filing
17 Jun 2021
Next filing
14 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XGN Stock Option(right to buy) Award $0 +15K $0.00 15K 17 Jun 2021 Common Stock 15K $16.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is exercisable as it vests. The total number of shares of common stock subject to the option vests in 36 equal monthly installments over the three-year period beginning on July 17, 2021, subject to the Reporting Person's continued service to the Issuer through each such vesting date.